NEOPLASMS PANCREATIC
Clinical trials for NEOPLASMS PANCREATIC explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS PANCREATIC trials appear
Sign up with your email to follow new studies for NEOPLASMS PANCREATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for stubborn cancers
Disease control OngoingThis study tests a new drug called 9-ING-41, given alone or with chemotherapy, in adults with cancers that have not responded to standard treatments. The goal is to see if the drug is safe and can help control the disease. About 350 people with various advanced cancers, including…
Matched conditions: NEOPLASMS PANCREATIC
Phase: PHASE2 • Sponsor: Actuate Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New cocktail of targeted drugs and chemo takes on pancreatic cancer
Disease control OngoingThis study tests whether adding two targeted drugs (avutometinib and defactinib) to standard chemotherapy can help people with metastatic pancreatic cancer that hasn't been treated yet. About 40 adults with this cancer will receive the combination. The goal is to find the safest …
Matched conditions: NEOPLASMS PANCREATIC
Phase: PHASE1, PHASE2 • Sponsor: Verastem, Inc. • Aim: Disease control
Last updated Jun 26, 2026 13:18 UTC